Revenue of $9.8 million
Record 700 patients added to the pipeline
More than 300 Certified Prosthetists Orthotists have completed initial MyoPro® training
Conference call being held today at 4:30pm Eastern time
BURLINGTON, Mass. (May 7, 2025) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months ended March 31, 2025.
Financial and operating highlights for the first quarter of 2025 include the following (all comparisons are with the first quarter of 2024 unless otherwise indicated): Read more.